Roivant Sciences ROIV
NASDAQ ROIV
$41.85 +0.66 (+1.60%)
At close: Nov 11, 2026 · 4:00 PM EST

Roivant Sciences (ROIV) Price to Earnings (2023 - 2024)

Updated

Roivant Sciences' Price to Earnings came in at 1.76 for fiscal Q2 2025 (quarter ended Sep 30, 2024), up 6.7% from the prior quarter.

Analysis

Roivant Sciences (ROIV) Price to Earnings (2023 - 2024) Analysis & Trends

For FY2024 (ended Mar 31, 2024), Roivant Sciences' Price to Earnings was 1.96.

  • The five-year range for quarterly Price to Earnings is 1.65 (fiscal Q1 2025) to 2.02 (fiscal Q3 2024).
  • Business Quant data shows ROIV's Price to Earnings at 1.65 (Q1 2025), 1.96 (Q4 2024) and 2.02 (Q3 2024) in the three fiscal quarters before Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Roivant Sciences 29.81 Bn 13.51 Bn 31.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 1.76
Jun 30, 2024 1.65
Mar 31, 2024 1.96
Dec 31, 2023 2.02
API Access

Roivant Sciences Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=ROIV&period=max&api_key=YOUR_API_KEY